Brief: Biohit Q4 net sales up to EUR 1.1 million
26/02/2015 07:30
Feb 26 (Reuters) - Biohit Oyj BIOBV.HE :
* Q4 net sales 1.1 million euros ($1.25 million) versus 0.8
million euros year ago
* Q4 operating loss continuing operations 1.2 million euros
versus loss 1.5 million euros year ago
* Says board of directors proposes to annual general meeting
that no dividend be paid for financial year 2014
* Says net sales growth is expected in 2015
* Says company does not assess when result of its continuing
operations will turn to positive
* Says new, strategically significant projects will require
additional investments in 2015
* Says various placebo-controlled double-blind studies
assessing efficacy of Biohit's Acetium products in entirely new
indications are expected to be completed in 2015
Source text for Eikon: ID:nHSU5Jf2
Further company coverage: BIOBV.HE
($1 = 0.8807 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))